学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
Side effects of statins: Hepatitis versus "transaminitis" - Myositis versus "CPKitis"
被引:53
作者
:
Dujovne, CA
论文数:
0
引用数:
0
h-index:
0
机构:
Radiant Res Kansas City, Kansas Fdn Clin Pharmacol, Overland Pk, KS 66215 USA
Radiant Res Kansas City, Kansas Fdn Clin Pharmacol, Overland Pk, KS 66215 USA
Dujovne, CA
[
1
]
机构
:
[1]
Radiant Res Kansas City, Kansas Fdn Clin Pharmacol, Overland Pk, KS 66215 USA
来源
:
AMERICAN JOURNAL OF CARDIOLOGY
|
2002年
/ 89卷
/ 12期
关键词
:
D O I
:
10.1016/S0002-9149(02)02356-1
中图分类号
:
R5 [内科学];
学科分类号
:
1002 ;
100201 ;
摘要
:
引用
收藏
页码:1411 / 1413
页数:3
相关论文
共 11 条
[1]
Randomized comparison of the efficacy and safety of cerivastatin and pravastatin in 1030 hypercholesterolemic patients
Dujovne, CA
论文数:
0
引用数:
0
h-index:
0
机构:
Kansas Fdn Clin Pharmacol, Overland Pk, KS 66215 USA
Dujovne, CA
论文数:
引用数:
h-index:
机构:
Knopp, R
Kwiterovich, P
论文数:
0
引用数:
0
h-index:
0
机构:
Kansas Fdn Clin Pharmacol, Overland Pk, KS 66215 USA
Kwiterovich, P
Hunninghake, D
论文数:
0
引用数:
0
h-index:
0
机构:
Kansas Fdn Clin Pharmacol, Overland Pk, KS 66215 USA
Hunninghake, D
McBride, TA
论文数:
0
引用数:
0
h-index:
0
机构:
Kansas Fdn Clin Pharmacol, Overland Pk, KS 66215 USA
McBride, TA
论文数:
引用数:
h-index:
机构:
Poland, M
[J].
MAYO CLINIC PROCEEDINGS,
2000,
75
(11)
: 1124
-
1132
[2]
EXPANDED CLINICAL-EVALUATION OF LOVASTATIN (EXCEL) STUDY RESULTS .4. ADDITIONAL PERSPECTIVES ON THE TOLERABILITY OF LOVASTATIN
DUJOVNE, CA
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
DUJOVNE, CA
CHREMOS, AN
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
CHREMOS, AN
POOL, JL
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
POOL, JL
SCHNAPER, H
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
SCHNAPER, H
BRADFORD, RH
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
BRADFORD, RH
SHEAR, CL
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
SHEAR, CL
HIGGINS, J
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
HIGGINS, J
DOWNTON, M
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
DOWNTON, M
FRANKLIN, FA
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
FRANKLIN, FA
NASH, DT
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
NASH, DT
GOULD, AL
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
GOULD, AL
LANGENDORFER, A
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
LANGENDORFER, A
[J].
AMERICAN JOURNAL OF MEDICINE,
1991,
91
: S25
-
S30
[3]
DUJOVNE CA, 1976, CLIN PHARMACOL THER, V19, P352
[4]
DUJOVNE CA, 1968, P SOC EXP BIOL MED, V128, P561
[5]
Ethical, medical and legal issues for the use of placebos in future lipid intervention trials
Dujovne, CA
论文数:
0
引用数:
0
h-index:
0
机构:
Kansas Fdn Clin Phamracol, Kansas City, KS USA
Dujovne, CA
Tonkin, AM
论文数:
0
引用数:
0
h-index:
0
机构:
Kansas Fdn Clin Phamracol, Kansas City, KS USA
Tonkin, AM
[J].
CURRENT OPINION IN LIPIDOLOGY,
2001,
12
(06)
: 599
-
600
[6]
Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia
Guyton, JR
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Dept Med, Sarah W Stedman Nutr Ctr, Durham, NC 27710 USA
Guyton, JR
Goldberg, AC
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Dept Med, Sarah W Stedman Nutr Ctr, Durham, NC 27710 USA
Goldberg, AC
Kreisberg, RA
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Dept Med, Sarah W Stedman Nutr Ctr, Durham, NC 27710 USA
Kreisberg, RA
Sprecher, DL
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Dept Med, Sarah W Stedman Nutr Ctr, Durham, NC 27710 USA
Sprecher, DL
Superko, HR
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Dept Med, Sarah W Stedman Nutr Ctr, Durham, NC 27710 USA
Superko, HR
O'Connor, CM
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Dept Med, Sarah W Stedman Nutr Ctr, Durham, NC 27710 USA
O'Connor, CM
[J].
AMERICAN JOURNAL OF CARDIOLOGY,
1998,
82
(06)
: 737
-
743
[7]
Illingworth RD, 2001, CURR MED RES OPIN, V17, P43
[8]
MCKENNEY J, 1994, JAMA-J AM MED ASSOC, V27, P673
[9]
Update on the US Food and Drug Administration regulatory approach to over-the-counter cholesterol-lowering drugs
Orloff, DG
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA
US FDA, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA
Orloff, DG
[J].
AMERICAN JOURNAL OF CARDIOLOGY,
1998,
81
(8A)
: 79F
-
79F
[10]
Guidance for industry - Over-the-counter treatment of hypercholesterolemia
Weintraub, M
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, US Dept HHS, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA
US FDA, US Dept HHS, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA
Weintraub, M
[J].
AMERICAN JOURNAL OF CARDIOLOGY,
1998,
81
(8A)
: 78F
-
78F
←
1
2
→
共 11 条
[1]
Randomized comparison of the efficacy and safety of cerivastatin and pravastatin in 1030 hypercholesterolemic patients
Dujovne, CA
论文数:
0
引用数:
0
h-index:
0
机构:
Kansas Fdn Clin Pharmacol, Overland Pk, KS 66215 USA
Dujovne, CA
论文数:
引用数:
h-index:
机构:
Knopp, R
Kwiterovich, P
论文数:
0
引用数:
0
h-index:
0
机构:
Kansas Fdn Clin Pharmacol, Overland Pk, KS 66215 USA
Kwiterovich, P
Hunninghake, D
论文数:
0
引用数:
0
h-index:
0
机构:
Kansas Fdn Clin Pharmacol, Overland Pk, KS 66215 USA
Hunninghake, D
McBride, TA
论文数:
0
引用数:
0
h-index:
0
机构:
Kansas Fdn Clin Pharmacol, Overland Pk, KS 66215 USA
McBride, TA
论文数:
引用数:
h-index:
机构:
Poland, M
[J].
MAYO CLINIC PROCEEDINGS,
2000,
75
(11)
: 1124
-
1132
[2]
EXPANDED CLINICAL-EVALUATION OF LOVASTATIN (EXCEL) STUDY RESULTS .4. ADDITIONAL PERSPECTIVES ON THE TOLERABILITY OF LOVASTATIN
DUJOVNE, CA
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
DUJOVNE, CA
CHREMOS, AN
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
CHREMOS, AN
POOL, JL
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
POOL, JL
SCHNAPER, H
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
SCHNAPER, H
BRADFORD, RH
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
BRADFORD, RH
SHEAR, CL
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
SHEAR, CL
HIGGINS, J
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
HIGGINS, J
DOWNTON, M
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
DOWNTON, M
FRANKLIN, FA
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
FRANKLIN, FA
NASH, DT
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
NASH, DT
GOULD, AL
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
GOULD, AL
LANGENDORFER, A
论文数:
0
引用数:
0
h-index:
0
机构:
MERCK SHARP & DOHME LTD,W POINT,PA 19486
LANGENDORFER, A
[J].
AMERICAN JOURNAL OF MEDICINE,
1991,
91
: S25
-
S30
[3]
DUJOVNE CA, 1976, CLIN PHARMACOL THER, V19, P352
[4]
DUJOVNE CA, 1968, P SOC EXP BIOL MED, V128, P561
[5]
Ethical, medical and legal issues for the use of placebos in future lipid intervention trials
Dujovne, CA
论文数:
0
引用数:
0
h-index:
0
机构:
Kansas Fdn Clin Phamracol, Kansas City, KS USA
Dujovne, CA
Tonkin, AM
论文数:
0
引用数:
0
h-index:
0
机构:
Kansas Fdn Clin Phamracol, Kansas City, KS USA
Tonkin, AM
[J].
CURRENT OPINION IN LIPIDOLOGY,
2001,
12
(06)
: 599
-
600
[6]
Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia
Guyton, JR
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Dept Med, Sarah W Stedman Nutr Ctr, Durham, NC 27710 USA
Guyton, JR
Goldberg, AC
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Dept Med, Sarah W Stedman Nutr Ctr, Durham, NC 27710 USA
Goldberg, AC
Kreisberg, RA
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Dept Med, Sarah W Stedman Nutr Ctr, Durham, NC 27710 USA
Kreisberg, RA
Sprecher, DL
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Dept Med, Sarah W Stedman Nutr Ctr, Durham, NC 27710 USA
Sprecher, DL
Superko, HR
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Dept Med, Sarah W Stedman Nutr Ctr, Durham, NC 27710 USA
Superko, HR
O'Connor, CM
论文数:
0
引用数:
0
h-index:
0
机构:
Duke Univ, Med Ctr, Dept Med, Sarah W Stedman Nutr Ctr, Durham, NC 27710 USA
O'Connor, CM
[J].
AMERICAN JOURNAL OF CARDIOLOGY,
1998,
82
(06)
: 737
-
743
[7]
Illingworth RD, 2001, CURR MED RES OPIN, V17, P43
[8]
MCKENNEY J, 1994, JAMA-J AM MED ASSOC, V27, P673
[9]
Update on the US Food and Drug Administration regulatory approach to over-the-counter cholesterol-lowering drugs
Orloff, DG
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA
US FDA, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA
Orloff, DG
[J].
AMERICAN JOURNAL OF CARDIOLOGY,
1998,
81
(8A)
: 79F
-
79F
[10]
Guidance for industry - Over-the-counter treatment of hypercholesterolemia
Weintraub, M
论文数:
0
引用数:
0
h-index:
0
机构:
US FDA, US Dept HHS, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA
US FDA, US Dept HHS, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA
Weintraub, M
[J].
AMERICAN JOURNAL OF CARDIOLOGY,
1998,
81
(8A)
: 78F
-
78F
←
1
2
→